Pramipexole use and the risk of pneumonia

BACKGROUND: Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole. It is uncertain whether pramipexole or other dopamine agonists increase the risk of pneumonia. METHODS: We used t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ernst, Pierre, Renoux, Christel, Dell'Aniello, Sophie, Suissa, Samy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522019/
https://ncbi.nlm.nih.gov/pubmed/23020246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-113
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller